{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:54:06Z","timestamp":1791114846604,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,27]]},"DOI":"10.1097\/01.tp.0000151644.85832.b5","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T04:01:02Z","timestamp":1110945662000},"page":"655-661","source":"Crossref","is-referenced-by-count":52,"title":["Inhibition of Matrix Metalloproteinases During Chronic Allograft Nephropathy in Rats"],"prefix":"10.1097","volume":"79","author":[{"given":"Jens","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Antus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","first-page":"2495","article-title":"Collagens in chronic rejection of rat renal allografts.","volume":"7","author":"Inkinen","year":"1997","journal-title":"Transplant Proc"},{"key":"R2-10-20210129","first-page":"61","article-title":"Matrix metalloproteinases (MMPs) in renal fibrosis.","volume":"49","author":"Norman","year":"1996","journal-title":"Kidney Int"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00041552-199507000-00014","article-title":"Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation?","volume":"4","author":"Baricos","year":"1995","journal-title":"Curr Opin Neph Hyperten"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1021\/jm00078a019","article-title":"Inhibition of Matrix Metalloproteinases by N-carboxyalkyl peptides.","volume":"36","author":"Chapman","year":"1993","journal-title":"J Med Chem"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/15.12.2041","article-title":"Circulating levels of matrix metalloproteinases MMP-3, and MMP-2 in renal transplant recipients with chronic transplant nephropathy.","volume":"15","author":"Rodrigo","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R6-10-20210129","first-page":"115","article-title":"Changes in serum concentrations of matrix metalloproteinases. Tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.","volume":"95","author":"Akiyama","year":"1997","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V113574","article-title":"Matrix metalloproteinases in renal development.","volume":"11","author":"Lenz","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0966-3274(02)00150-8","article-title":"Differential expression of MMP-2\/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.","volume":"11","author":"Ermolli","year":"2003","journal-title":"Transplant Immunol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0041-1345(96)00669-0","article-title":"Collagens in chronic rejection of rat renal allografts.","volume":"29","author":"Inkinen","year":"1997","journal-title":"Transplant Proc"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000058345","article-title":"Matrix metalloproteinases and their inhibitions in experimental renal scarring.","volume":"10","author":"Johnson","year":"2002","journal-title":"Exp Nephrol"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1600-6135.2003.00277.x","article-title":"Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation.","volume":"4","author":"Soccal","year":"2004","journal-title":"Am J Transplant"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1046\/j.1523-1755.2000.00097.x","article-title":"Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat.","volume":"57","author":"Forbes","year":"2000","journal-title":"Kidney Int"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1046\/j.1365-2168.2000.01499.x","article-title":"Molecular changes in extracellular matrix turnover after renal ischaemia-reperfusion injury.","volume":"87","author":"Jain","year":"2000","journal-title":"Br J Surg"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"F893","DOI":"10.1152\/ajprenal.00328.2003","article-title":"Angiostatin and matrix metalloproteinase expression following ischemic acute renal failure.","volume":"286","author":"Basile","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R15-10-20210129","first-page":"754","article-title":"Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy.","volume":"125","author":"Sharma","year":"1995","journal-title":"J Lab Clin Med"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000028023","article-title":"Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model.","volume":"66","author":"Gonzalez","year":"1998","journal-title":"Pathobiology"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2143(96)90031-1","article-title":"Matrix metalloproteinase (stromelysin-1) increase the albumin permeability of isolated rat glomeruli.","volume":"128","author":"Sharma","year":"1996","journal-title":"J Lab Clin Med"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj2540609","article-title":"Degradation of glomerular basement membrane by purified mammalian metalloproteinases.","volume":"254","author":"Baricos","year":"1998","journal-title":"Biocehm J"},{"key":"R19-10-20210129","first-page":"415","article-title":"Glomerular neutral metalloproteinase: characterization and activity in animal models of human glomerular disease.","volume":"1","author":"Le","year":"1992","journal-title":"Matrix (Suppl)"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.ATV.16.1.28","article-title":"Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor.","volume":"16","author":"Zempo","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-10-20210129","first-page":"F923","article-title":"Human glomeruli express TIMP-1 mRNA, and TIMP-2 protein and mRNA.","volume":"264","author":"Carome","year":"1993","journal-title":"Am J Physiol"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1681\/ASN.V561391","article-title":"Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli.","volume":"4","author":"Carome","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"26884","DOI":"10.1074\/jbc.271.43.26884","article-title":"Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB).","volume":"271","author":"Somasundaram","year":"1996","journal-title":"J Biol Chem"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1523-1755.2002.00148.x","article-title":"Early application of Met-RANTES ameliorates chronic allograft nephropathy.","volume":"61","author":"Song","year":"2002","journal-title":"Kidney Int"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0272-6386(96)90504-1","article-title":"Growth factor transcripts in rat renal transplants.","volume":"28","author":"Paul","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/stem.170237","article-title":"New drugs on the horizon: matrix metalloproteinase inhibitors.","volume":"17","author":"Rothenberg","year":"1999","journal-title":"Stem Cells"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1200\/JCO.2000.18.1.178","article-title":"Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12\u20139566 on a protracted oral daily dosing schedule in patients with solid malignancies.","volume":"18","author":"Rowinsky","year":"2000","journal-title":"J Clin Oncol"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1523-1755.2000.00926.x","article-title":"Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.","volume":"57","author":"Szabo","year":"2000","journal-title":"Kidney Int"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1432-2277.1994.tb01246.x","article-title":"Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts.","volume":"7","author":"Heemann","year":"1994","journal-title":"Transpl Int"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1046\/j.1523-1755.2001.00007.x","article-title":"Antiandrogens ameliorate chronic allograft nephropathy.","volume":"60","author":"Antus","year":"2001","journal-title":"Kidney Int"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0008-6363(02)00254-7","article-title":"Myocardial protection from ischemia\/reperfusion injury by targeted deletion of matrix metalloproteinase-9.","volume":"54","author":"Romanic","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/hmg\/10.15.1563","article-title":"Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via dystroglycan complex.","volume":"10","author":"Yamada","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1046\/j.1523-1755.2000.07713.x","article-title":"Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.","volume":"58","author":"McLennan","year":"2000","journal-title":"Kidney Int"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.1998.00965.x","article-title":"Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells.","volume":"54","author":"Pawluczyk","year":"1998","journal-title":"Kidney Int"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1681\/ASN.V8101525","article-title":"Macrophages promote prosclerotic responses in cultured rat mesangial cells: mechanism for the initiation of glomerulosclerosis.","volume":"8","author":"Pawluczyk","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1046\/j.1432-1033.2003.03760.x","article-title":"Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities.","volume":"270","author":"Van Den Steen","year":"2003","journal-title":"Eur J Biochem"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/excr.2000.5002","article-title":"Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.","volume":"10","author":"Yakubenko","year":"2000","journal-title":"Exp Cell Res"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1523-1755.2003.00828.x","article-title":"Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production.","volume":"63","author":"Chana","year":"2003","journal-title":"Kidney Int"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000159155","article-title":"Postnatal growth of the heart and its blood vessels.","volume":"33","author":"Hudlicka","year":"1996","journal-title":"J Vasc Res"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000052602","article-title":"Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function.","volume":"9","author":"Ziswiler","year":"2001","journal-title":"Exp Nephrol"},{"key":"R42-10-20210129","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/diab.42.10.1425","article-title":"STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats.","volume":"42","author":"Reckelhoff","year":"1993","journal-title":"Diabetes"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s001250050785","article-title":"Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.","volume":"40","author":"Schaefer","year":"1997","journal-title":"Diabetologica"},{"key":"R44-10-20210129","doi-asserted-by":"crossref","first-page":"B365","DOI":"10.1093\/gerona\/55.8.B365","article-title":"Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex.","volume":"55","author":"Gaglliano","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R45-10-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000045733","article-title":"Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain).","volume":"86","author":"Uchio","year":"2000","journal-title":"Nephron"},{"issue":"Suppl","key":"R46-10-20210129","first-page":"S32","article-title":"Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies.","volume":"62","author":"Heidland","year":"1997","journal-title":"Kidney Int"},{"key":"R47-10-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00007890-199909270-00010","article-title":"Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function.","volume":"68","author":"Cuhaci","year":"1999","journal-title":"Transplantation"},{"key":"R48-10-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V102271","article-title":"Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-\u03b2) isoforms in TGF-\u03b2 transgenic mice.","volume":"10","author":"Mozes","year":"1999","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000151644.85832.B5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:43:30Z","timestamp":1785851010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200503270-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,27]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000151644.85832.b5","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3,27]]}}}